Common Stock, Shares, Outstanding of Marker Therapeutics, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Marker Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Marker Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 16,700,000, a 88% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Marker Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 16,700,000 +7,800,000 +88% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 11,300,000 +2,400,000 +27% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 11,200,000 +2,300,000 +26% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 10,700,000 +1,800,000 +20% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 8,900,000 +100,000 +1.1% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 8,900,000 +100,000 +1.1% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 8,900,000 +100,000 +1.1% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 8,900,000 +500,000 +6% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 8,800,000 -74,800,000 -89% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 8,800,000 -74,800,000 -89% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 8,800,000 -74,700,000 -89% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 8,400,000 +100,000 +1.2% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 83,600,000 +500,000 +0.6% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 83,600,000 +500,000 +0.6% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 83,500,000 +500,000 +0.6% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 8,300,000 -42,400,000 -84% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 83,100,000 +35,100,000 +73% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 83,100,000 +36,500,000 +78% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 83,000,000 +36,500,000 +78% 31 Mar 2021 10-Q 12 May 2021 2021 Q1
Q4 2020 50,700,000 +5,000,000 +11% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 48,000,000 +2,300,000 +5% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 46,600,000 +1,100,000 +2.4% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 46,500,000 +1,000,000 +2.2% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 45,700,000 +300,000 +0.66% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 45,700,000 +31,900,000 +231% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 45,500,000 +31,900,000 +235% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 45,500,000 +34,900,000 +329% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 45,400,000 +34,800,000 +328% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 13,800,000 +3,300,000 +31% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 13,600,000 +3,441,007 +34% 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 10,600,000 +2,129,167 +25% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 10,600,000 +2,200,000 +26% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 10,500,000 +2,104,232 +25% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 10,158,993 -61,257,275 -86% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 8,470,833 -62,519,930 -88% 31 Mar 2017 10-Q 05 May 2017 2017 Q1
Q4 2016 8,400,000 +2,517,045 +43% 31 Dec 2016 10-K 23 Mar 2018 2017 FY
Q3 2016 8,395,768 -54,494,995 -87% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 71,416,268 +33,377,347 +88% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 70,990,763 +38,351,952 +118% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 5,882,955 -14,435,860 -71% 31 Dec 2015 10-K 14 Mar 2017 2016 FY
Q3 2015 62,890,763 +43,286,948 +221% 30 Sep 2015 10-Q/A 14 Apr 2016 2015 Q3
Q2 2015 38,038,921 +21,232,352 +126% 30 Jun 2015 10-Q/A 14 Apr 2016 2015 Q2
Q1 2015 32,638,811 +16,792,629 +106% 31 Mar 2015 10-Q/A 14 Apr 2016 2015 Q1
Q4 2014 20,318,815 +18,853,103 +1286% 31 Dec 2014 10-K 14 Apr 2016 2015 FY
Q3 2014 19,603,815 -124,704,700 -86% 30 Sep 2014 10-Q 19 Nov 2014 2014 Q3
Q2 2014 16,806,569 30 Jun 2014 10-Q 18 Aug 2014 2014 Q2
Q1 2014 15,846,182 -60,556,776 -79% 31 Mar 2014 10-Q/A 21 May 2014 2014 Q1
Q4 2013 1,465,712 +701,682 +92% 31 Dec 2013 10-K 15 Apr 2015 2014 FY
Q3 2013 144,308,515 +70,446,761 +95% 30 Sep 2013 10-Q 19 Nov 2013 2013 Q3
Q1 2013 76,402,958 +22,073,052 +41% 31 Mar 2013 10-Q 19 Aug 2013 2013 Q2
Q4 2012 764,030 -51,309,430 -99% 31 Dec 2012 10-K/A 17 Apr 2014 2013 FY
Q3 2012 73,861,754 +26,501,033 +56% 30 Sep 2012 10-Q 19 Nov 2012 2012 Q3
Q2 2012 54,329,906 +7,519,185 +16% 30 Jun 2012 10-Q/A 12 Sep 2012 2012 Q2
Q1 2012 54,329,906 31 Mar 2012 10-Q 21 May 2012 2012 Q1
Q4 2011 52,073,460 +11,817,433 +29% 31 Dec 2011 10-K 15 May 2013 2012 FY
Q3 2011 47,360,721 30 Sep 2011 10-Q 21 Nov 2011 2011 Q3
Q2 2011 46,810,721 30 Jun 2011 10-Q 22 Aug 2011 2011 Q2
Q4 2010 40,256,027 31 Dec 2010 10-K 16 Apr 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.